ArticleGut microbiology2026
Gut microbiome in preterm infants with different weight gain outcomes.
Article in Gut microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Background: Inadequate in-hospital weight gain among very low birth weight (VLBW; <1500g) infants is associated with adverse outcomes. Although microbiome alterations are linked to malnutrition in older children, their association with VLBW weight gain outcomes remains unclear. Objective: To evaluate associations between fecal microbiome composition, functional gene pathways, and metabolomic profile, and abnormal weight gain in VLBW infants. Methods: Prospective cohort study of VLBW infants from birth to hospital discharge with weekly fecal sampling. Inadequate weight gain was defined at 36 weeks post-menstrual age, as growth faltering (decline in weight-for-age z-scores from birth) and growth failure (<3 Results: Among 101 enrolled infants, 54% had growth faltering (28 mild; 26 moderate-severe), and 18% had growth failure. The two outcomes rarely co-occurred (n=7). Microbiome diversity and taxonomic composition changed with age but did not differ by growth outcomes. Infants with moderate-to-severe faltering had reduced abundance of the glycolysis/gluconeogenesis pathway. Infants with growth failure showed a significant lag in microbiome maturity. Metabolite concentrations measured in a subset (n=46) were not significantly different in the study groups. Conclusion: Abnormal weight gain in VLBW infants was not associated with major differences in microbial compositional or fecal metabolite levels. Differences identified in pathway analysis and in microbiome maturation may help focus future efforts to investigate the gut microbiome's role in VLBW weight gain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.